Not applicableStudy completedNCT05689450
What this trial is testing
Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder
Who this might be right for
Febrile Neutropenia (FN)
University Hospital, Basel, Switzerland 92